AML Clinical Trial Participation Disparities | Impact on Access, Outcomes, and Inclusion Strategies
https://vimeo.com/925566796 What are AML clinical trial disparities, outcomes, and solutions for inclusion? Expert Dr. Sara Taveras Alam from UTHealth Houston discusses patient factors that impact access, underrepresented patient groups, and patient advice…
How Is AML Care Impacted by Bone Marrow Biopsy Results?
https://vimeo.com/925566573 What is the impact of bone marrow biopsy results on AML care? Expert Dr. Sara Taveras Alam from UTHealth Houston shares how test results are weighed along with patient factors to…
AML Diagnosis | Exploring Bone Marrow Biopsy and Alternatives
https://vimeo.com/925566047 What are the purpose and alternatives to bone marrow biopsy? Expert Dr. Sara Taveras Alam from UTHealth Houston explains what’s involved in bone marrow biopsy, what is analyzed, patient advice for…
Advancements in AML Treatment | Tailoring Therapies to Individual Patients
What are the latest AML treatment advancements? Expert Dr. Sara Taveras Alam from UTHealth Houston discusses how treatments have advanced over recent years with personalized therapies beyond a one-size-fits-all approach. [ACT]IVATION TIP…
Evolving Myelofibrosis Treatment Options: What You Should Know
https://vimeo.com/925945364 Myelofibrosis treatment and care is evolving quickly so it’s essential to understand your options and work with your healthcare team when making treatment decisions. In this webinar, Dr. Gaby…
Dr. Sara Taveras Alam: Why Is It Important for You to Empower Patients?
Dr. Sara Taveras Alam: Why Is It Important for You to Empower Patients? from Patient Empowerment Network on Vimeo. How do care providers empower patients, and why is it important?…
Kidney Cancer Patient Expert Q&A: Dr. Moshe Ornstein
https://vimeo.com/925106006 START HERE bridges the expert and patient voice, enabling patients facing a kidney cancer diagnosis to feel comfortable asking precise questions of their healthcare team. In this program, Dr….
CAR T-Cell Therapy | Care and Monitoring Post-Treatment
https://vimeo.com/925006628 How are myeloma patients monitored after CAR T-cell therapy? Myeloma expert and researcher Dr. Beth Faiman explains the testing that takes place following CAR T-cell therapy, how long monitoring…
CAR T-Cell Therapy for Myeloma | What Are the Advantages?
https://vimeo.com/925006501 How has CAR T-cell therapy transformed care for myeloma patients? Myeloma expert and researcher Dr. Beth Faiman shares results from the KarMMa study that compared CAR T-cell therapy versus…
Recovering From CAR T-Cell Therapy | What Can Myeloma Patients Expect?
https://vimeo.com/925006363 What can myeloma patients expect after undergoing CAR T-cell therapy? Myeloma expert and researcher Dr. Beth Faiman discusses returning to life after the CAR T process, advice for physical…
CAR T-Cell Therapy | Key Considerations for Myeloma Patients
https://vimeo.com/925005821 Myeloma expert and researcher Dr. Beth Faiman shares key considerations when planning for CAR T-cell therapy. Dr. Faiman reviews which patients qualify for CAR T-cell therapy, key aspects for…
What Side Effects Are Possible Following CAR T-Cell Therapy?
https://vimeo.com/925006154 Myeloma expert and researcher Dr. Beth Faiman shares an overview of both rare and mild side effects that may affect people who have undergone CAR T-cell therapy. Dr. Faiman…